drugset / Trial / NCT00328094

Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery

NCT00328094

Terminated 242 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

Aggressive intraoperative and postoperative management of blood glucose may substantially decrease perioperative cardiovascular and infectious complications in diabetic and non-diabetic patients undergoing vascular surgery. The purpose of this study is to compare the tight versus traditional blood glucose control in diabetics and non-diabetics undergoing vascular surgery in regard to their postoperative fatal and nonfatal cardiac outcomes, and the secondary effects such as rate of infections, overall morbidity and 30-day mortality.

Timeline

Start
2006-03
Primary completion
2008-04
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Intravenous